• Globe Newswire

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Globenewswire -

• Globe Newswire

Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US

Globenewswire -

• Globe Newswire

King Faisal Specialist Hospital and Research Centre Celebrates the Success of Treating 100 Patients with Lymphocytic Leukemia Using CAR T-Cells

• Globe Newswire

IMAGIO consortium receives Innovative Health Initiative EUR 24 million grant to improve cancer treatments

• Globe Newswire

Mercurius Health equips Robert Janker Klinik with integrated oncology solutions from Philips and Elekta